Heteroresistance Interdisciplinary Research Unit

  • Weiss, David D.S (PI)
  • Andersson, Dan (CoPI)
  • Levin, Bruce B.R (CoPI)
  • Andersson, Dan D (CoPI)
  • Jacob, Jesse Thomas (CoPI)
  • Jacob, Jesse J.T (CoPI)
  • Kim, Minsu (CoPI)
  • Levin, Bruce (CoPI)
  • Weiss, David S. (CoPI)

Project: Research project

Project Details

Description

NARRATIVE Antibiotic resistant bacteria are a growing crisis that not only threaten our ability to treat infections but also advances of modern medicine that rely on antibiotics, such as transplants, chemotherapy and even routine surgeries. Heteroresistance is an underappreciated and emerging form of antibiotic resistance which is poorly understood. The Heteroresistance Interdisciplinary Research Unit (HR-IRU) will elucidate the mechanisms causing heteroresistance, its dynamics and prevalence among clinical isolates, leading to translational interventions to improve human health.
StatusFinished
Effective start/end date3/5/212/28/23

Funding

  • National Institute of Allergy and Infectious Diseases: US$2,172,273.00

ASJC Scopus Subject Areas

  • Cancer Research

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.